Clinical trials: Dravet Syndrome (DS)

Dravet Syndrome (DS)

Biomarkers of Neurodegeneration, Synaptic Plasticity and Neuroinflammation in Dravet Syndrome

• Not yet recruiting
• Age: All ages
• Observational study

Dravet syndrome (DS) is a developmental and epileptic encephalopathy, usually caused by de novo pathogenic SCN1A variants, characterized by early-onset prolonged febrile seizures, subsequent drug-resistant polymorphic epilepsy…

Trial name

TEMBO-DS (NCT07801404)

Where

9 sites in Italy

Volunteers

90 people, healthy volunteers welcome

Sponsor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS